This Solicitation opportunity from Texas was posted on July 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection Services

Closed

IC-RFP-2026-003State & Local

Submission Closed08/07/2026, 11:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

SLED

Confirmatory Drug Testing Services (GC/MS)This subcontract involves providing high-complexity confirmatory drug testing services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize Gas Chromatography/Mass Spectrometry (GC/MS) to analyze samples that have triggered positive initial screens, ensuring that all certified confirmatory test reports are delivered within 72 hours of sample submission. To be eligible, the laboratory must be licensed and accredited within the State of Hawaii and fully equipped with the necessary GC/MS instrumentation. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

DEADLINE

Initial Drug Screening Services (EMIT/Equivalent)This subcontract involves providing initial drug screening services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize the EMIT system or an approved equivalent to execute Screening Panels I and II, which cover substances including amphetamines, cocaine, cannabinoids, opiates, alcohol, and fentanyl. All initial screening test results must be delivered within 72 hours of sample submission. To qualify, the provider must operate a laboratory equipped for rapid screening that maintains appropriate accreditation. This opportunity falls under NAICS code 621511 and has a response deadline of November 23, 2026.

Department of Judiciary

POSTED

DEADLINE

Urine Specimen Collection ServicesThis subcontract for Urine Specimen Collection Services supports prime contractors on Department of Judiciary projects throughout the State of Hawaii. The selected subcontractor is responsible for the physical collection and secure delivery of urine specimens, operating seven days a week at designated facilities. To ensure the integrity of the process, the provider must adhere to strict, Judiciary-approved written procedures designed to prevent tampering. Eligible providers must maintain a physical collection facility located within the O‘ahu, Maui, Hawai‘i, or Kaua‘i circuits. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

DEADLINE

Statewide Sample Collection, Drug Screen & Confirmatory Testing

Solicitation # J28030

The Department of Judiciary for the State of Hawaii is soliciting bids under solicitation J28030 for statewide sample collection, initial drug screening, and confirmation testing. The contractor is responsible for collecting urine specimens from individuals referred by the First, Second, Third, and Fifth Circuit courts at their own or an approved subcontractor's facilities. Initial screenings must utilize the EMIT system or an approved equivalent, while confirmation testing must be performed using gas chromatography/mass spectrometry by a company licensed and accredited in Hawaii. The contractor must provide these services seven days a week and submit written procedures to the Officer-in-Charge to ensure samples are not tampered with during collection. The contract is for an initial twenty-four month term from July 1, 2027, through June 30, 2029, with the possibility of two additional twelve-month extensions. Award will be granted to the lowest responsive and responsible bidder, with preferences considered for Hawaii-based products and other statutory categories. Payment is based on the actual number of samples collected per month at the unit bid cost, with invoices submitted separately for each circuit. The contractor must maintain compliance with various Hawaii state laws, including tax clearances, unemployment insurance, and prepaid health care requirements.

Department of Judiciary

POSTED

DEADLINE

Clinical STI Screening and Treatment ServicesThe Clinical STI Screening and Treatment Services subcontract involves providing clinical screening, diagnosis, and medical management of sexually transmitted infections for prime contractors working on East Riding of Yorkshire Council sexual health projects. The scope of work specifically emphasizes Chlamydia screening for females aged 15 to 24 and the early detection of HIV to minimize late-stage presentations. These services are delivered using clinical diagnostic tools and medical examination facilities to ensure patients are accurately diagnosed and treated. The contract is aligned with the Public Health Outcomes Framework indicators, with a primary focus on delivering treated patients and reporting detection rates. Interested parties must respond by November 23, 2026, for this initiative managed by the East Riding of Yorkshire Council under NAICS code 621511.

East Riding of Yorkshire Council

POSTED

DEADLINE

RRC Drug and Alcohol Testing Laboratory ServicesThis subcontract for Residential Reentry Center projects under the Department of Justice involves providing specialized drug and alcohol testing laboratory services for prime contractors. The selected provider will be responsible for the collection and analysis of urine samples to detect narcotics and alcohol, ensuring the delivery of accurate test results and comprehensive reporting. The service provider must maintain strict adherence to regulatory standards, specifically 42 CFR Part 493 (CLIA), P.S. 6060, and P.S. 6590. Performance for this contract is centered in Springfield, falling under NAICS code 621511. Responses are due by November 12, 2026.

Residential Reentry - Co

POSTED

DEADLINE

Substance Abuse Testing and SurveillanceThis subcontract, titled Substance Abuse Testing and Surveillance, is issued by the Department of Justice for Residential Reentry projects. The selected provider will perform random drug and alcohol testing for prime contractors, utilizing urine surveillance, narcotic identification, and breathalyzer equipment. All activities, including testing intervals at facilities and during home visits, must be conducted in strict accordance with BOP P.S. 6060 and P.S. 6590 guidelines to ensure the delivery of verified results and compliance reports. The opportunity is categorized under NAICS code 621511 and was posted on October 28, 2026. Interested parties must submit their responses by the deadline of November 27, 2026.

Residential Reentry - Co

POSTED

DEADLINE

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Solicitation # Project_1717

Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.

Supply Chain Coordination Limited

POSTED

DEADLINE

Pathology ServicesThis subcontract for Pathology Services involves providing diagnostic pathology support for prime contractors working on projects for the Kingston University Higher Education Corporation. The scope of work includes the collection of biological samples and the execution of laboratory analysis utilizing specialized diagnostic equipment and pathology software to deliver comprehensive test results and diagnostic reports. To ensure quality and compliance, the provider must hold recognized laboratory accreditation, such as ISO 15189 or equivalent UK standards. Interested parties must submit their responses by the deadline of November 27, 2026, as specified in the solicitation posted on October 28, 2026.

Kingston University Higher Education Corporation

POSTED

DEADLINE

REBID - IN HOUSE DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140325

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003540 to establish a four year requirements contract for in house drug testing services. This procurement covers professional medical services and clinical laboratory reagents and tests, specifically falling under NIGP codes 94874 and 19300. The contract is intended to provide comprehensive drug monitoring and diagnostic capabilities for the agency over a multi year period. Interested bidders must submit their proposals electronically via the Euna portal by the deadline of November 10, 2026. The Port Authority has ceased public bid openings, making electronic submission the only acceptable method. All activities related to this solicitation are conducted in accordance with Title VI of the Civil Rights Act of 1964 to ensure full and fair opportunity without discrimination. Procurement operations are managed out of the New York office located at 150 Greenwich Street, and further documentation or technical assistance can be obtained through the official Port Authority website or by contacting their procurement support specialists.

The Port Authority of New York and New Jersey

POSTED

DEADLINE

REBID - FEDERAL DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140324

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003539, a four year requirements contract for federal drug testing services. This rebid covers professional medical services and clinical laboratory reagents and tests, specifically falling under NIGP codes 94874 and 19300. The contract is intended for state wide performance within New York. Bids must be submitted electronically via the Euna portal by November 10, 2026, at 11:00 AM, as the Port Authority has temporarily ceased public bid openings. The agency emphasizes compliance with Title VI of the Civil Rights Act of 1964, ensuring full and fair opportunity for all businesses regardless of race, color, national origin, age, or disability. All inquiries and submissions are managed by the Procurement Operations Bid/RFP Custodian located at 150 Greenwich Street, New York, New York.

The Port Authority of New York and New Jersey

POSTED

DEADLINE

Clinical Blood Donor Panel Testing (Reference Laboratory Services)This subcontract involves providing clinical blood donor panel testing as a reference laboratory service for prime contractors supporting the Department of Veterans Affairs in North Chicago. The scope of work includes screening for various pathogens, including HIV, HBV, HCV, West Nile Virus, Chagas, Babesia, HTLV-I/II, and Anti-CMV, utilizing FDA-approved platforms. The service provider is responsible for managing specimen storage and conducting confirmation testing on all reactive results, with a strict requirement to deliver test result files within 24 hours. To ensure clinical quality and safety, the contractor must maintain CLIA certification and adhere to rigorous standards set by AABB, CAP, TJC, OSHA, the CDC, and the DoD. This opportunity falls under NAICS code 621511 and is managed through the Department of Veterans Affairs Network Contract Office 12.

252-NETWORK Contract Office 12 (36C252)

POSTED

2 days ago

DEADLINE

in 5 days

AI Contract Overview

Integral Care is soliciting proposals for comprehensive clinical laboratory testing and on-site specimen collection services to support individuals receiving behavioral health and community-based care in Texas. The selected provider will deliver a wide range of diagnostic laboratory services including blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI and HIV screening, tuberculosis testing, and other medically necessary diagnostics. The provider must demonstrate the ability to handle high-volume testing demands with reliable turnaround times for routine and expedited services such as CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, and urine toxicology. STAT and rapid testing options with clearly defined timelines are required to support crisis stabilization, medication management, and clinical decision-making. Proposals must detail operational capacity, staffing, equipment, and logistical capabilities to ensure consistent, high-quality service delivery across multiple community-based locations. All questions must be submitted by Monday, July 27, 2026, and proposals are due no later than Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time. The solicitation is managed by Integral Care in Austin, Texas, with primary contacts listed for inquiries and correspondence.

General Info

Integral Care seeks provider for comprehensive lab testing and on-site specimen collection across Texas community health sites.

Agency

Texas → INTEGRAL CARE

NAICS

621511 - Medical Laboratories

Place of Performance

TX, USA

Set-Aside

NONE

Documents

IC-RFP-2026-003 Comprehensive Laboratory & Specimen Collection Services Fee Summary

sow

High

RFP IC-RFP-2026-003 Comprehensive Laboratory Testing and Specimen Collection Services

rfp

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 17

Solicitation

Response DeadlineAug 7

Deadline has passed

Submission Closed

08/07/2026, 11:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyTexas → INTEGRAL CARE

Contacts3 people available

OfficeAUSTIN, TX, 78707, USA

Organization / Agency

Texas → INTEGRAL CARE

Office AddressAUSTIN, TX, 78707, USA

Contacts

Christina Lundy

contact@example.gov

+1 (555) 000-0000

Scott RuffCHIEF ADMIN OFFICER

contact@example.gov

+1 (555) 000-0000

HANS RIEDELFACILITIES DIRECTOR

contact@example.gov

+1 (555) 000-0000

Full Description

Integral Care is seeking proposals from qualified clinical laboratory service providers to deliver comprehensive laboratory testing and on-site specimen collection services supporting individuals receiving behavioral health and related community-based services.The selected provider will furnish timely and reliable routine, specialized, and expedited laboratory services to support diagnostic evaluation, medication management, metabolic monitoring, crisis stabilization, substance use treatment, and ongoing clinical decision-making. Anticipated services include blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI screening, HIV and hepatitis screening, tuberculosis testing, and other medically necessary clinical laboratory diagnostics.Proposers should demonstrate the operational capacity to support high-volume testing, including CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, therapeutic drug monitoring, urine toxicology, and infectious disease screening. Proposers must also describe available STAT, rapid, or other expedited testing options and applicable turnaround times. Questions Due: Monday, July 27, 2026. Proposal Deadline: Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS